journal article·2021-06

Pre-clinical MRI-guided intravesical instillation theranosis of bladder cancer by tumor-selective oxygen nanogenerator

Weiqiang Lin, Hongxing Liu, Lingwu Chen, Junxing Chen, Dong Zhang, Qingqing Cheng, Fang Yang, Qinsong Zeng, Tianfeng Chen

Nano Today· Volume 38
Publisher page

Abstract

Abstract Bladder tumor intravesical instillation is usually compromised by hypoxia and low target efficiency. Herein, a nanoscale oxygen generator (PLZ4@SeD) encapsulating superparamagnetic iron oxide nanoparticles (SPIONs) and organoselenium (SeD) with PLZ4 peptide as the BCa-targeting moiety was constructed for intravesical instillation to overcome the resistance caused by hypoxia and achieve the real-time MR imaging-guided theranosis of patient-derived bladder tumors. The real-time monitoring of intact bladders excised from 3 BCa patients showed that PLZ4@SeD could not only precisely target the tumor region inside the bladder but also specifically enhance MRI contrast efficacy. As expected, PLZ4@SeD could efficiently accumulate in BCa cells and could “infect” different batches of cells, thus enhancing its tumor permeability. Moreover, PLZ4@SeD consumed excess H2O2 inside the tumor through the Fenton reaction, which relieved hypoxia resistance and effectively inhibited the proliferation of BCa cells. Taken together, these results suggest that the nanoscale oxygen generator PLZ4@SeD hold potential for application in MRI-guided preclinical BCa theranosis by ameliorating hypoxic conditions and elevating chemotherapeutic efficacy.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Bladder and Urothelial Cancer Treatments · Cancer, Hypoxia, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (61)

Show source-provided references
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Mucoadhesive cationic polypeptide nanogel with enhanced penetration for efficient intravesical chemotherapy of bladder cancer10.1002/advs.201800004 ↗
3. Repeat transurethral resection in non–muscle-invasive bladder cancer: a systematic review10.1016/j.eururo.2018.02.014 ↗
4. Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor10.4111/icu.2018.59.1.10 ↗
5. Fluorinated polyethylenimine to enable transmucosal delivery of photosensitizer‐conjugated catalase for photodynamic therapy of orthotopic bladder tumors postintravesical instillation
6. Sylvester · Eur. Urol. · 2016 · 69 · 23110.1016/j.eururo.2015.05.050 ↗
7. Value of an immediate intravesical instillation of mitomycin C in patients with non–muscle-invasive bladder cancer: a prospective multicentre randomised study in 2243 patients10.1016/j.eururo.2017.06.038 ↗
8. The economics of bladder cancer: costs and considerations of caring for this disease10.1016/j.eururo.2014.01.006 ↗
9. Structural absorption by barbule microstructures of super black bird of paradise feathers10.1038/s41467-017-02088-w ↗
10. Novel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancer10.1016/j.biomaterials.2016.07.026 ↗
11. Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation10.1016/j.biocel.2008.07.014 ↗
12. Rational design of selenadiazole derivatives to antagonize hyperglycemia-induced drug resistance in cancer cells10.1002/asia.201403409 ↗
13. Highly stable selenadiazole derivatives induce bladder cancer cell apoptosis and inhibit cell migration and invasion through the activation of ROS-mediated signaling pathways10.1039/C6DT02045C ↗
14. Nanotechnology for multimodal synergistic cancer therapy10.1021/acs.chemrev.7b00258 ↗
15. Efficient encapsulation of biocompatible nanoparticles in exosomes for cancer theranostics10.1016/j.nantod.2020.100964 ↗
16. Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies10.1021/acs.chemrev.5b00589 ↗
17. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release10.1021/acs.chemrev.5b00346 ↗
18. Clinical cancer nanomedicine10.1016/j.nantod.2019.02.005 ↗
19. Precise delivery of a multifunctional nanosystem for MRI-guided cancer therapy and monitoring of tumor response by functional diffusion-weighted MRI10.1039/C8TB03153C ↗
20. Tumour microenvironment responsive nanoconstructs for cancer theranostic10.1016/j.nantod.2019.03.007 ↗
21. SU-E-J-52: the automated detection and scoring algorithm for bladder transitional cell carcinoma screening with PLZ4 coated beads10.1118/1.3611820 ↗
22. Novel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancer10.1016/j.biomaterials.2016.07.026 ↗
23. Tumor-targeting multifunctional micelles for imaging and chemotherapy of advanced bladder cancer10.2217/nnm.12.150 ↗
24. Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand10.1186/1476-4598-10-9 ↗
25. Hypoxia-targeted drug delivery10.1039/C8CS00304A ↗
26. Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement10.1016/j.nantod.2018.06.008 ↗
27. Continuous O2-evolving MnFe2O4 nanoparticle-anchored mesoporous silica nanoparticles for efficient photodynamic therapy in hypoxic cancer10.1021/jacs.7b05559 ↗
28. Magnetic reactive oxygen species nanoreactor for switchable magnetic resonance imaging guided cancer therapy based on pH-sensitive Fe5C2@Fe3O4 nanoparticles10.1021/acsnano.9b01740 ↗
29. Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized fenton reaction10.1002/anie.201510031 ↗
30. Chemodynamic therapy: tumour microenvironment‐mediated fenton and fenton‐like reactions10.1002/anie.201805664 ↗
31. Tumor microenvironment-responsive intelligent nanoplatforms for cancer theranostics10.1016/j.nantod.2020.100851 ↗
32. Physical, chemical, and biological structures based on ROS-sensitive moieties that are able to respond to oxidative microenvironments10.1002/adma.201505376 ↗
33. Nanoparticles-based magnetic and photo induced hyperthermia for cancer treatment10.1016/j.nantod.2019.100795 ↗
34. Recent progress of chemodynamic therapy-induced combination cancer therapy10.1016/j.nantod.2020.100946 ↗
35. Protoporphyrin IX (PpIX)-coated superparamagnetic iron oxide nanoparticle (SPION) nanoclusters for magnetic resonance imaging and photodynamic therapy10.1002/adfm.201707030 ↗
36. Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (vesical imaging-reporting and data system)10.1016/j.eururo.2018.04.029 ↗
37. Polymeric micelles: theranostic co-delivery system for poorly water-soluble drugs and contrast agents10.1016/j.biomaterials.2018.03.054 ↗
38. Surface engineering of iron oxide nanoparticles for targeted cancer therapy10.1021/ar2000277 ↗
39. Magnetic gold nanotriangles by microwave-assisted polyol synthesis10.1039/C5NR03113C ↗
40. Double-slit photoelectron interference in strong-field ionization of the neon dimer10.1038/s41467-018-07882-8 ↗
41. Highly catalytic nanodots with renal clearance for radiation protection10.1021/acsnano.6b00321 ↗
42. Radiosensitive core/satellite ternary heteronanostructure for multimodal imaging-guided synergistic cancer radiotherapy10.1016/j.biomaterials.2019.119545 ↗
43. TRPM8-regulated calcium mobilization plays a critical role in synergistic chemosensitization of Borneol on Doxorubicin10.7150/thno.45861 ↗
44. Construction of urokinase-type plasminogen activator receptor-targeted heterostructures for efficient photothermal chemotherapy against cervical cancer to achieve simultaneous anticancer and antiangiogenesis10.1021/acsami.9b15751 ↗
45. Triangle-shaped tellurium nanostars potentiate radiotherapy by boosting checkpoint blockade immunotherapy10.1016/j.matt.2020.08.027 ↗
46. Designing multifunctional cancer-targeted nanosystem for magnetic resonance molecular imaging-guided theranostics of lung cancer10.1080/10717544.2018.1494224 ↗
47. Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy10.1021/acs.chemrev.5b00148 ↗
48. Cooperative assembly of magneto-nanovesicles with tunable wall thickness and permeability for MRI-guided drug delivery10.1021/jacs.8b00884 ↗
49. Designing core–shell gold and selenium nanocomposites for cancer radiochemotherapy10.1021/acsnano.7b01346 ↗
50. Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy10.1038/s41565-019-0485-z ↗
51. Hypoxia-activated PEGylated conditional aptamer/antibody for cancer imaging with improved specificity10.1021/jacs.9b05063 ↗
52. Metal-organic frameworks-based nanozymes for combined cancer therapy10.1016/j.nantod.2020.100920 ↗
53. Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer10.1038/bjc.2013.240 ↗
54. Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer10.1038/bjc.2014.315 ↗
55. A gene signature for selecting benefit from hypoxia modification of radiotherapy for high-risk bladder cancer patients10.1158/1078-0432.CCR-17-0038 ↗
56. O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia10.7150/thno.22465 ↗
57. Jones · Clin. Cancer Res. · 2001 · 7 · 1263
58. Stable black phosphorus/Bi2O3 heterostructures for synergistic cancer radiotherapy10.1016/j.biomaterials.2018.04.022 ↗
59. Systematic acute and subchronic toxicity evaluation of polysaccharide–protein complex-functionalized selenium nanoparticles with anticancer potency10.1039/C9BM01104H ↗
60. Cellular localization of iron(II) polypyridyl complexes determines their anticancer action mechanisms10.1016/j.biomaterials.2015.08.031 ↗
61. Fluorinated polymer mediated transmucosal peptide delivery for intravesical instillation therapy of bladder cancer